Key result
Cardiovascular risk factor control in patients with type 2 diabetes and nonalcoholic fatty liver disease requires urgent clinical action to improve patient outcomes.
An editorial discussing the need for improved cardiovascular risk factor control in patients with type 2 diabetes and nonalcoholic fatty liver disease.
No abstract yet. The journal hasn't published one we can show.
No takes yet. Share an insight, caveat, or question.
Cyrielle Caussy (2023) studied this question. Cardiovascular risk factor control in patients with type 2 diabetes and nonalcoholic fatty liver disease requires urgent clinical action to improve patient outcomes.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: